Tag: infants
-
RSV Vaccines Are Safe and Effective, Review Finds
What the Cochrane review found A new Cochrane review synthesizes evidence from multiple trials to assess vaccines and related RSV prophylactics. The analysis includes maternal vaccines given during pregnancy, vaccines intended for older adults, and monoclonal antibody approaches used in infants. Across diverse populations and settings, the review concludes that RSV vaccines are generally safe…
-
Nirsevimab Reduces RSV Hospitalizations in US Infants During 2024-25 Season
Overview New real‑world data from the 2024-2025 RSV season indicate that nirsevimab, a monoclonal antibody given to infants to prevent severe respiratory syncytial virus (RSV) infection, provides powerful protection. In a recent research letter analyzing administration patterns and hospitalizations, researchers report a clear reduction in RSV-related hospital stays among U.S. infants who received nirsevimab compared…
-
RSV vaccines are safe and effective, review finds
What the Cochrane Review Found A new Cochrane review concludes that vaccines targeting respiratory syncytial virus (RSV) are safe and effective in reducing serious illness among the populations most at risk. By pooling results from randomized trials and real-world studies, researchers found that RSV vaccination strategies can lower hospitalizations, severe respiratory disease, and related complications…
-
RSV Vaccines Confirmed Safe and Effective, Review Finds
What the Cochrane Review Found A new Cochrane Collaboration review synthesizes data on vaccines designed to protect against respiratory syncytial virus (RSV). The analysis indicates that RSV vaccines are generally safe and offer protection for groups most at risk of severe illness, including older adults and infants. While individual vaccines vary in their level of…
-
Expanded RSV Protection in Nova Scotia: What You Need to Know
Overview of RSV and Its Impact Respiratory syncytial virus (RSV) is a common virus that can cause significant respiratory illness, particularly in infants and older adults. In Nova Scotia, the government has recognized the need for increased protection against this virus and is expanding access to the RSV vaccine. Who Is Affected? Starting September 10,…
-
Expanded Access to RSV Protection in Nova Scotia
Introduction to RSV and Its Impact Respiratory syncytial virus (RSV) is a common virus that affects the respiratory tract, particularly in infants and the elderly. It can lead to severe respiratory illnesses, making it a significant health concern in Nova Scotia and beyond. To tackle this issue, the Nova Scotia government has announced an expansion…
-
Nova Scotia Launches Free RSV Vaccine Program for Seniors and Infants
Introduction to Nova Scotia’s New RSV Vaccine Program In a significant health initiative, Nova Scotia is investing $6.9 million to launch a free vaccination program aimed at protecting vulnerable groups, including infants and seniors, from respiratory syncytial virus (RSV). This program represents a pivotal step in public health, targeting the traditionally high-risk demographics and expanding…